BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1705275)

  • 1. Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin.
    Kalayci C; Johnson PJ; Raby N; Metivier EM; Williams R
    J Hepatol; 1990 Nov; 11(3):349-53. PubMed ID: 1705275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol.
    Johnson PJ; Kalayci C; Dobbs N; Raby N; Metivier EM; Summers L; Harper P; Williams R
    J Hepatol; 1991 Jul; 13(1):120-7. PubMed ID: 1655867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of arterial injection of lipiodol-adriamycin emulsion on hepatocellular carcinoma].
    Sonoyama T; Hironaka T; Inaba S; Tsukamoto K; Nonaka M; Makino H; Kohnosu H; Oka T
    Nihon Gan Chiryo Gakkai Shi; 1986 May; 21(4):773-9. PubMed ID: 3020138
    [No Abstract]   [Full Text] [Related]  

  • 4. Adriamycin-lipiodol suspension for i.a. chemotherapy of hepatocellular carcinoma.
    Katagiri Y; Mabuchi K; Itakura T; Naora K; Iwamoto K; Nozu Y; Hirai S; Ikeda N; Kawai T
    Cancer Chemother Pharmacol; 1989; 23(4):238-42. PubMed ID: 2538250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Eight cases of non-resectable hepatocellular carcinoma surviving for more than 3 years after Lipiodol administration].
    Shirabe K; Kanematsu T; Utsunomiya T; Furuta T; Yamagata M; Matsumata T; Sugimachi K; Yasumori K; Masuda K
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2974-7. PubMed ID: 2551238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter oily chemoembolization with high doses of adriamycin in the treatment of large hepatocellular carcinoma (10 cm or more in diameter).
    Nakamura H; Hashimoto T; Inoue Y; Inoue K; Akaji H; Sawada S
    Radiat Med; 1990; 8(5):188-90. PubMed ID: 1963695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
    Leung WT; Lau WY; Ho S; Chan M; Leung N; Lin J; Ho KC; Metreweli C; Johnson PJ; Li AK
    J Nucl Med; 1994 Aug; 35(8):1313-8. PubMed ID: 7519259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
    Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C; Sakata Y; Shimamura Y; Jinno K; Takahashi A; Takayasu K; Tamura K; Nagasue N; Nakanishi Y; Makino M; Masuzawa M; Yumoto Y; Mori T; Oda T
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatic arterial infusion chemotherapy of hepatocellular carcinoma].
    Ishibashi T; Okajima K; Isozaki H; Morita S; Nakata E; Nishimura J; Iga C; Amioka K; Tanimura M; Hara H
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2778-81. PubMed ID: 2551222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Repermeability of portal vein after intra-arterial lipiodol chemotherapy in patients with hepatocellular carcinoma. Report of 3 cases].
    Derhy S; Bessis L; Atallah R; Ajavon Y; Eisele G; Roche A
    Gastroenterol Clin Biol; 1990; 14(11):893-5. PubMed ID: 2177429
    [No Abstract]   [Full Text] [Related]  

  • 11. Unresectable hepatocellular carcinoma: survival and prognostic factors after lipiodol chemoembolisation in 89 patients.
    Dumortier J; Chapuis F; Borson O; Davril B; Scoazec JY; Poncet G; Henry L; Boillot O; Mion F; Berger F; Partensky C; Paliard P; Valette PJ
    Dig Liver Dis; 2006 Feb; 38(2):125-33. PubMed ID: 16389002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hepatocellular carcinoma by intraarterial injection of adriamycin/mitomycin C oil suspension (ADMOS) alone or combined with cis-diaminodichloroplatinum (CDDP).
    Inoue H; Miyazono N; Hori A; Miyake S; Satake M; Kanetsuki I; Nishida H; Ikeda K; Nakajo M
    Acta Radiol; 1993 Jul; 34(4):388-91. PubMed ID: 8391290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary complication following intra-arterial infusion of lipiodol-adriamycin emulsion for hepatocellular carcinoma, report of a case].
    Samejima M; Tamura S; Kodama T; Yuuki Y; Takasaki J; Sekiva R; Koga Y; Watanabe K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jan; 50(1):24-8. PubMed ID: 2158647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Accumulating patterns of lipiodol and therapeutic effect of combination therapy with ADMOS and CDDP two-route infusion in hepatocellular carcinoma].
    Hiraki Y; Kobayashi H; Itoh Y; Yano T; Ikeda K; Sonoda T; Shinohara S
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2525-30. PubMed ID: 2843117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
    Mabed M; Esmaeel M; El-Khodary T; Awad M; Amer T
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):492-9. PubMed ID: 19453695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unresectable fibrolamellar hepatocellular carcinoma treated with intra-arterial lipiodolised doxorubicin. A case report.
    Spence RA; Rosen A; Krige JE; Blumgart RL; Temple-Camp CR; Terblanche J
    S Afr Med J; 1987 Nov; 72(10):701-3. PubMed ID: 2825364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study.
    Partensky C; Sassolas G; Henry L; Paliard P; Maddern GJ
    Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial internal radiation therapy with I-131 Lipiodol for multifocal hepatocellular carcinoma: immediate and long-term results.
    Kajiya Y; Kobayashi H; Nakajo M
    Cardiovasc Intervent Radiol; 1993; 16(3):150-7. PubMed ID: 8392913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraarterial injection therapy of newly developed cisplatin-phosphatidyl choline-lipiodol suspension for hepatocellular carcinoma.
    Isomoto I; Aikawa H; Mori H; Matsunaga N; Ajimu A; Fukuda T; Ogasawara M
    Radiat Med; 1992; 10(1):19-25. PubMed ID: 1374923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of intra-arterial injection of a lipiodol-adriamycin suspension combined with arterial embolization on hepatocellular carcinoma].
    Sasaki Y; Imaoka S; Nakamori S; Ishikawa O; Ohigashi H; Koyama H; Taniguchi K; Iwanaga T; Fujita M; Kawamoto S
    Nihon Gan Chiryo Gakkai Shi; 1985 Aug; 20(7):1357-65. PubMed ID: 3001204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.